−37.7
Aprea Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−25.0
FY23:
−12.2
FY24:
−13.6
FY25:
−12.9
Change from FY23 to FY24
millions USD
FY21:
–
FY22:
–
FY23:
−0.09
FY24:
−0.02
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
1.75
FY22:
0.68
FY23:
5.14
FY24:
14.8
FY25:
4.64
(positive)
Change from FY23 to FY24
millions USD
FY21:
–
FY22:
–
FY23:
−12.3
FY24:
−13.6
FY25:
–
All amounts in millions USD